Il Network del Distretto | Page 17 | Distretto Toscano Scienze della Vita

141 results

Magnetic Resonance Center - CERM

Via L.Sacconi, 6 - 50019 - Sesto Fiorentino

cerm@cerm.unifi.it

Magnetic Resonance Center (CERM) is an infrastructure in the field of structural biology in general and life sciences in particular. It is a laboratory of national and international importance, specialized in structural investigations through nuclear magnetic resonance spectroscopy (NMR). The Centre specialises in structural biology, molecular biology, design and development of new drugs, metabolomics and bioinformatics, and houses some of the most advanced NMR high-field instrumentation in the world (up to 950 MHz) for the spectroscopic and biophysical characterization of biological systems, alongside molecular biology laboratories and biophysical instrumentation. CERM is the Italian node of the pan-European ESFRI Instruct infrastructure (www.structuralbiology.eu) as a reference for the development and application of NMR spectroscopy in the field of integrated structural biology and molecular systems biology.

MATBIO
Laboratorio per lo Sviluppo di Materiali per Biosistemi

Via A. Moro, 2 - 53100 - Siena

agnese.magnani@unisi.it

"The Laboratory for the Development of Materials for Biosystems (MATBIO) conducts research on multifunctional materials for regenerative medicine and tissue engineering, polysaccharides and liposome systems, micro and nano structured systems and biosensors, molecular recognition processes in solution and at the solid/liquid interface, applications of infrared spectroscopy and secondary ion mass spectrometry for the study of biological materials and systems. High resolution nuclear magnetic resonance (NMR) applications are also being developed for model analysis studies of metabolic processes of unicellular organisms and studies of binder-receptor interaction.
Another field of research is the agrifood-energy sector, in particular with the study of processes of production and bio-transformation of vegetable biomass into biofuels and the development of processes of radiation transfer in aquatic ecosystems (analysis of dissolved organic components and interaction with solar and ultraviolet radiation, photodegradation and photoactivation for the production of biomass of aquatic origin).

Materia Medica Processing

Via Niccolò Copernico, 19 - 39100 - Bolzano-BZ

info@materiamedicaprocessing.eu

Thanks to the most advanced technologies and specific know-how on cannabinoid chemistry, Materia Medica Processing (MMP) produces THC free highly tested products extracted from hemp. All the raw material comes from organic farming, non-GMO and of European origin only, produced by selected farmers whose MMP follows the entire production cycle. The extraction and purification technologies respect the phytochemical profile of the plant and allow a high concentration of cannabidiols (CBD), maintaining the entire spectrum of non-psychoactive terpenes and cannabinoids and at the same time eliminating all psychoactive compounds (THC Free). The extraction and purification process takes place using only biological chemicals and food solvents. The uniformity and effectiveness of the extracts is tested and guaranteed by means of certificates of analysis issued for each production batch. MMP's analytical laboratory has years of experience in pharmaceutical extraction and CBD broad spectrum purification and uses the most advanced analytical techniques to offer a product in line with the highest standards.

Mattioli Engineering

Viale Petrarca, 80/82 - 50041 - Calenzano-FI

info@mattioliengineering.it

Born from the experience of its founding partners in the medical industry, Mattioli Engineering develops, manufactures and markets medical devices for dermatology, skin care, cosmetic surgery, plastic surgery and general surgery, based on technologies such as dermoelectroporation, microdermabrasion, endoporation, pulsed light, laser. Mattioli Engineering developed its first microdermabrasion system in 1991, and since then has continued to develop systems with unique features based on proprietary technology protected by patents and according to GMP quality standards. Today Ultrapeel systems, recognized as standard for this type of technology, FDA approved, are available anywhere in the world, with a presence in the U.S. market of more than 1,500 units installed and in the international market with more than 4,000. The Ultrapeel microdermabrasion systems have been completed with the introduction of the new patented method called Dermoelectroporation and the Transderm device for the transdermal transmission of drugs that can be used as an alternative to injections, approved by the FDA in 2003.

MEDEA

Via Dante Alighieri, 12 - 54100 - Massa-MS

info@medeaproject.eu

MEDEA has 20 years of experience in the management and development of innovative regional and international projects, in particular in the eHealth, e-government and active ageing domains. It has recognized skills in fundraising, project and financial management of complex projects, drafting of strategic development plans with technical and financial planning, support to processes of organizational change and deployment of organizational solutions and processes. In particular, MEDEA collaborates with public and private companies by carrying out the development of research projects, the definition of strategic policy actions in the context of international projects, the drafting and management of projects financed through EU programmes.

MEDIBASE

Via di Gonfienti, 5/C/59 - 59100 - Prato-PO

medibase@medibase.it

MediBase srl, founded in 1995, operates in the field of phytotherapy and medical dietetics. It was one of the first companies to deal with nutraceuticals through the preparation of products exclusively addressed to the doctors and distributed through the pharmacies, parapharmacies, nursing homes and hospitals channel. All Medibase products are controlled by quantitative determinations and according to high quality standards. The formulation of preparations, the choice of active ingredients and their titration are carried out by the Research and Development department on the basis of accurate studies and analysis of clinical works, published in the most prestigious international scientific journals. MediBase products include active preparations for the central nervous system, for cardiovascular prevention, gastrointestinal problems, chondroprotectors with anti-inflammatory activity and a new line specifically for children's products (Puer).

Pages